Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


12.07.2021

1 Antimicrob Agents Chemother
2 Clin Infect Dis
4 Emerg Infect Dis
23 J Antimicrob Chemother
6 J Clin Microbiol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. WESTGEEST AC, Schippers EF, Delfos NM, Ellerbroek LJ, et al
    Complicated carriage with methicillin-resistant Staphylococcus aureus (MRSA): evaluation of the effectiveness of decolonization regimens advised in the Dutch national guideline.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0025721. doi: 10.1128/AAC.00257.
    PubMed         Abstract available


    Clin Infect Dis

  2. IMLAY HN, Kaul DR
    Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
    Clin Infect Dis. 2020 Nov 17. pii: 5983750. doi: 10.1093/cid/ciaa1713.
    PubMed         Abstract available

  3. YAHAV D, Tau N, Shepshelovich D
    Assessment of Data Supporting the Efficacy of New Antibiotics for Treating Infections Caused by Multidrug-resistant Bacteria.
    Clin Infect Dis. 2021;72:1968-1974.
    PubMed         Abstract available


    Emerg Infect Dis

  4. SCOULLAR MJL, Boeuf P, Peach E, Fidelis R, et al
    Mycoplasma genitalium and Other Reproductive Tract Infections in Pregnant Women, Papua New Guinea, 2015-2017.
    Emerg Infect Dis. 2021;27:894-904.
    PubMed         Abstract available

  5. NONGHANPHITHAK D, Chaiprasert A, Smithtikarn S, Kamolwat P, et al
    Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.
    Emerg Infect Dis. 2021;27:813-822.
    PubMed         Abstract available

  6. WON EJ, Choi MJ, Kim MN, Yong D, et al
    Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018.
    Emerg Infect Dis. 2021;27:779-788.
    PubMed        

  7. MOHAN T, Nguyen HT, Kniss K, Mishin VP, et al
    Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020.
    Emerg Infect Dis. 2021;27:1953-1957.
    PubMed         Abstract available


    J Antimicrob Chemother

  8. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed         Abstract available

  9. ENGONE-ONDO JD, Mouinga-Ondeme A, Lekana-Douki SE, Diane A, et al
    High rate of virological failure and HIV drug resistance in semi-rural Gabon and implications for dolutegravir-based regimen efficacy.
    J Antimicrob Chemother. 2021;76:1051-1056.
    PubMed         Abstract available

  10. JONES JC, Pascua PNQ, Harrington WN, Webby RJ, et al
    Multiple polymerase acidic (PA) I38X substitutions in influenza A(H1N1)pdm09 virus permit polymerase activity and cause reduced baloxavir inhibition.
    J Antimicrob Chemother. 2021;76:957-960.
    PubMed         Abstract available

  11. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed         Abstract available

  12. MASHE T, Leekitcharoenphon P, Mtapuri-Zinyowera S, Kingsley RA, et al
    Salmonella enterica serovar Typhi H58 clone has been endemic in Zimbabwe from 2012 to 2019.
    J Antimicrob Chemother. 2021;76:1160-1167.
    PubMed         Abstract available

  13. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed         Abstract available

  14. KAO SW, Liu ZH, Wu TS, Ku SW, et al
    Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
    J Antimicrob Chemother. 2021;76:722-728.
    PubMed         Abstract available

  15. BUTLER DA, Rana AP, Krapp F, Patel SR, et al
    Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
    J Antimicrob Chemother. 2021;76:671-679.
    PubMed         Abstract available

  16. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed         Abstract available

  17. PHAM HT, Alves BM, Yoo S, Xiao MA, et al
    Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir.
    J Antimicrob Chemother. 2021;76:639-647.
    PubMed         Abstract available

  18. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed         Abstract available

  19. KRAGH KN, Gijon D, Maruri A, Antonelli A, et al
    Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.
    J Antimicrob Chemother. 2021;76:1001-1009.
    PubMed         Abstract available

  20. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed         Abstract available

  21. ABDI B, Chebbi M, Wirden M, Teyssou E, et al
    No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
    J Antimicrob Chemother. 2021;76:1553-1557.
    PubMed         Abstract available

  22. LI JZ, Stella N, Choudhary MC, Javed A, et al
    Impact of pre-existing drug resistance on risk of virological failure in South Africa.
    J Antimicrob Chemother. 2021;76:1558-1563.
    PubMed         Abstract available

  23. MERNISSI T, Bodeau S, Andre C, Zahr N, et al
    An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients.
    J Antimicrob Chemother. 2021;76:1643-1646.
    PubMed        

  24. YADAV K, Garoff L, Huseby DL, Hughes D, et al
    Phenotypic and genetic barriers to establishment of horizontally transferred genes encoding ribosomal protection proteins.
    J Antimicrob Chemother. 2021;76:1441-1447.
    PubMed         Abstract available

  25. DELAUGERRE C, Nere ML, Eymard-Duvernay S, Armero A, et al
    Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
    J Antimicrob Chemother. 2021;76:1286-1293.
    PubMed         Abstract available

  26. BROWN JA, Amstutz A, Nsakala BL, Seeburg U, et al
    Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial.
    J Antimicrob Chemother. 2021;76:1294-1298.
    PubMed         Abstract available

  27. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed         Abstract available

  28. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed         Abstract available

  29. FELICIO MR, Silveira GGOS, Oshiro KGN, Meneguetti BT, et al
    Polyalanine peptide variations may have different mechanisms of action against multidrug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2021;76:1174-1186.
    PubMed         Abstract available

  30. SEMENGUE ENJ, Armenia D, Inzaule S, Santoro MM, et al
    Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
    J Antimicrob Chemother. 2021;76:1277-1285.
    PubMed         Abstract available


    J Clin Microbiol

  31. SUKHUM KV, Jean S, Wallace M, Anderson N, et al
    Genomic Characterization of Emerging Bacterial Uropathogen Neisseria meningitidis, Which Was Misidentified as Neisseria gonorrhoeae by Nucleic Acid Amplification Testing.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  32. CAO Y, Parmar H, Gaur RL, Lieu D, et al
    Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second-line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum.
    J Clin Microbiol. 2020 Dec 9. pii: JCM.02314-20. doi: 10.1128/JCM.02314.
    PubMed         Abstract available

  33. KLEIN M, Bacher J, Barth S, Atrzadeh F, et al
    Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  34. YEE R, Dien Bard J, Simner PJ
    The Genotype-to-Phenotype Dilemma: How Should Laboratories Approach Discordant Susceptibility Results?
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

  35. MARRERO ROLON R, Cunningham SA, Mandrekar JN, Polo ET, et al
    Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool.
    J Clin Microbiol. 2021 Feb 3. pii: JCM.03040-20. doi: 10.1128/JCM.03040.
    PubMed         Abstract available

  36. LIU HC, Gao YL, Li DF, Zhao XY, et al
    Value of Xpert MTB/RIF Using Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis.
    J Clin Microbiol. 2020 Nov 11. pii: JCM.02170-20. doi: 10.1128/JCM.02170.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: